Commentary
Drug Development for Rare Diseases: Challenges and Regulatory Initiatives
Bax BE*
Reader in Rare Diseases, Cell Biology and Genetics Research Centre, St George's University of London, UK
- *Corresponding Author:
- Bridget E Bax
Reader in Rare Diseases, Molecular & Clinical Sciences Research Institute
Cell Biology and Genetics Research Centre, St George's University of London
Cranmer Terrace, London, SW17 0RE, UK
Tel: + 44-0-20-8266-6836
E-mail: bebax@sgul.ac.uk
Received date: May 10, 2017; Accepted date: May 11, 2017; Published date: May 12, 2017
Citation: Bridget E Bax (2017) Drug Development for Rare Diseases: Challenges and Regulatory Initiatives. Arch Sci 1:107. doi:10.4172/science.1000107
Copyright: © 2017 Bax BE. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Spanish
Chinese
Russian
German
French
Japanese
Portuguese
Hindi 